European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
p16/Ki-67 dual staining as a predictive value for cervical cancer compared to other conventional triage tools: a descriptive literature review
p16/Ki-67 dual staining as a predictive value for cervical cancer compared to other conventional triage tools: a descriptive literature review
DOI: 10.22514/ejgo.2024.062
The effects of adjunctive interventions on cervical skin health post-chemotherapy: a systematic review and meta-analysis
The effects of adjunctive interventions on cervical skin health post-chemotherapy: a systematic review and meta-analysis
DOI: 10.22514/ejgo.2024.063
Automated breast cancer mass diagnosis: leveraging artificial intelligance for detection and classification
Automated breast cancer mass diagnosis: leveraging artificial intelligance for detection and classification
DOI: 10.22514/ejgo.2024.064
Comparing loop electrosurgical procedure pathology results in the inpatient and outpatient setting
Comparing loop electrosurgical procedure pathology results in the inpatient and outpatient setting
DOI: 10.22514/ejgo.2024.065
Effects of oncoplastic breast-conserving surgery on the psychological status, quality of life and survival prognosis of patients with early-stage breast cancer
Effects of oncoplastic breast-conserving surgery on the psychological status, quality of life and survival prognosis of patients with early-stage breast cancer
DOI: 10.22514/ejgo.2024.066
Survival outcomes of neoadjuvant therapy for the treatment of stage IVB endometrial adenocarcinoma
Survival outcomes of neoadjuvant therapy for the treatment of stage IVB endometrial adenocarcinoma
DOI: 10.22514/ejgo.2024.067
Unveiling the lymph node drainage route in stage IB1 to IIA2 cervical cancer: insights from a retrospective cohort study
Unveiling the lymph node drainage route in stage IB1 to IIA2 cervical cancer: insights from a retrospective cohort study
DOI: 10.22514/ejgo.2024.068
Three serum miRNAs as potential biomarkers for early diagnosis of cervical cancer
Three serum miRNAs as potential biomarkers for early diagnosis of cervical cancer
DOI: 10.22514/ejgo.2024.070
Diagnostics and treatment of uterine sarcomas: challenges of a low-volume tertiary centre
Diagnostics and treatment of uterine sarcomas: challenges of a low-volume tertiary centre
DOI: 10.22514/ejgo.2024.071
Significance of HR-HPV E6/E7 mRNA detection to screen the severity of cervical cancer in relation to age
Significance of HR-HPV E6/E7 mRNA detection to screen the severity of cervical cancer in relation to age
DOI: 10.22514/ejgo.2024.072
Beta-Caryophyllene can inhibit the proliferation and autophagy of HPV16-infected immortalized cervical epithelial cells
Beta-Caryophyllene can inhibit the proliferation and autophagy of HPV16-infected immortalized cervical epithelial cells
DOI: 10.22514/ejgo.2024.073
PD-L1 in a South African cohort of endometrial carcinomas: directions for the future
PD-L1 in a South African cohort of endometrial carcinomas: directions for the future
DOI: 10.22514/ejgo.2024.074
Ketamine inhibits endometrial cancer cell growth and motility by inducing ferroptosis
Ketamine inhibits endometrial cancer cell growth and motility by inducing ferroptosis
DOI: 10.22514/ejgo.2024.075
Mismatch repair proteins evaluation in endometrial carcinoma: clinicopathological features and prognostic implications
Mismatch repair proteins evaluation in endometrial carcinoma: clinicopathological features and prognostic implications
DOI: 10.22514/ejgo.2024.076
ZNF671 restrains endometrial cancer cell growth and stemness through the Wnt/β-catenin pathway
ZNF671 restrains endometrial cancer cell growth and stemness through the Wnt/β-catenin pathway
DOI: 10.22514/ejgo.2024.077
The COVID-19 pandemic's ripple effects: investigating the impact of COVID-19 on endometrial cancer in a large UK regional cancer centre
The COVID-19 pandemic's ripple effects: investigating the impact of COVID-19 on endometrial cancer in a large UK regional cancer centre
DOI: 10.22514/ejgo.2024.078
Application of transumbilical paring and retrieving techniques in laparoscopic myomectomy
Application of transumbilical paring and retrieving techniques in laparoscopic myomectomy
DOI: 10.22514/ejgo.2024.079
Management of advanced epithelial ovarian cancer in the older patient: an age stratified cohort study of a gynaecological cancer centre in Southern England
Management of advanced epithelial ovarian cancer in the older patient: an age stratified cohort study of a gynaecological cancer centre in Southern England
DOI: 10.22514/ejgo.2024.080
Colposcopic biopsy findings in ASCUS or normal cervical cytology patients with high-risk HPV positivity
Colposcopic biopsy findings in ASCUS or normal cervical cytology patients with high-risk HPV positivity
DOI: 10.22514/ejgo.2024.081
The impact of family-synchronized empowerment education on the feelings of shame and quality of life of patients discharged with catheters following major surgery for cervical cancer
The impact of family-synchronized empowerment education on the feelings of shame and quality of life of patients discharged with catheters following major surgery for cervical cancer
DOI: 10.22514/ejgo.2024.082
Efficacy and safety of cervical conization combined with neoadjuvant chemotherapy versus radical trachelectomy in early-stage cervical cancer treatment
Efficacy and safety of cervical conization combined with neoadjuvant chemotherapy versus radical trachelectomy in early-stage cervical cancer treatment
DOI: 10.22514/ejgo.2024.083
Next-generation sequencing analysis and TP53 mutation in a rare case of fallopian tube carcinosarcoma
Next-generation sequencing analysis and TP53 mutation in a rare case of fallopian tube carcinosarcoma
DOI: 10.22514/ejgo.2024.084
A case report on second fertility-preserving surgical management for early recurrence of borderline ovarian tumor in a young woman
A case report on second fertility-preserving surgical management for early recurrence of borderline ovarian tumor in a young woman
DOI: 10.22514/ejgo.2024.085
Robotic-assisted minimal access surgery for large ovarian mass in pregnancy: case report of two patients
Robotic-assisted minimal access surgery for large ovarian mass in pregnancy: case report of two patients
DOI: 10.22514/ejgo.2024.086
Published Ahead of Print
Quality of life and mental health among gynaecological cancer patients towards the end of COVID-19 pandemic
Quality of life and mental health among gynaecological cancer patients towards the end of COVID-19 pandemic
Online publish date: 08 May 2024
DOI: 10.22514/ejgo.2024.041
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Online publish date: 12 October 2023
DOI: 10.22514/ejgo.2023.073
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.072
Vulvar cancer in young woman—case report
Vulvar cancer in young woman—case report
Online publish date: 07 September 2023
DOI: 10.22514/ejgo.2023.070
Prognostic value of Ki-67 in patients with ovarian cancer
Prognostic value of Ki-67 in patients with ovarian cancer
Online publish date: 24 July 2023
DOI: 10.22514/ejgo.2023.051
Special Issues
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endoemtrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Selected Papers from the 2021 AGOA Society
Keywords: Gynecology Oncology;Endometrial Cancer;Ovarian Cancer;Vulvar Cancer;Breast Cancer;Aragón
Editor: Laura Baquedano Mainar, MD
Submission deadline: 15 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.